Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2019.12.18

Jay Stella

Jay Stella joins Sai Life Sciences as Chief Business Officer

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the appointment of Jay Stella as Chief Business Officer, to lead the overall business development and program management for the company. Jay will be based out of Cambridge, Massachusetts, United States and report to the CEO & Managing Director, Krishna Kanumuri.

Jay Stella brings over 25 years of leadership in the pharmaceutical and medical devices industries with extensive experience across R&D, Manufacturing, Business Development, Finance, and Post-M&A Integrations. He held positions of increasing responsibility at Millennium Pharmaceuticals and Takeda Pharmaceuticals for 15 years, across strategy & operations, business development, and integrations & divestitures, while also gaining significant experience in the Japanese cultural and business environment. Earlier, he worked for medium sized biotech companies, Biogen and Genetics Institute, where he held various financial and operational roles. Prior to the pharmaceutical industry, Jay worked in technical operations, manufacturing, planning, and strategic sourcing roles in the medical device industry. Jay received his MBA from Boston University and his Baccalaureate degree from the University of Vermont in Spanish with minors in Chemistry and Biology.

Making the announcement, Krishna Kanumuri said, “Inducting top-notch global leadership and scientific talent is a key priority as part of our transformative effort, Sai Nxt. We are delighted to have Jay on board in this exciting phase.”

Sai Nxt is an organization-wide initiative aimed at transforming the company into a new generation CDMO. With investments of over US $ 150 million between 2019 and 2023, the transformation focus is on three key areas – People & culture, Processes & automation, Infrastructure & scientific capabilities.

Commenting on his appointment, Jay Stella said, “I am very excited to join Sai Life Sciences at this pivotal point in the company’s journey. Sai’s vision to support global innovators bring 25 new medicines to life by 2025 is an inspiring one, and I look forward to playing a part in achieving it.”

Share article

More News

2024.02.08

Sai Life Sciences releases its Sustainability Report 2023

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), released its Sustainability Report 2022-2023. Developed in accordance with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, the fourth edition of the Sustainability report is based on the theme ‘Steadfast on Sustainability,’ and it articulates the company’s commitment to sustainability […]
Read more

2024.02.01

Sai Life Sciences augments DMPK capabilities to ace large-scale collaborations

To offer global big pharma clients cutting-edge, end-to-end drug metabolism and pharmacokinetics (DMPK) services, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), has expanded its DMPK capabilities. The expansion comprises the addition of 25,000 sq. ft. of state-of-the-art labs equipped with cutting-edge instrumentation enabling high-end automation. Complementing the expansion has been […]
Read more

2024.01.24

Sai Life Sciences strengthens discovery leadership

Sai Life Sciences, a leading global contract research, development, and manufacturing organization, announces the addition of two seasoned professionals to its leadership team. Dr Atul Tiwari joins as Vice President – Discovery Strategy & Business, while Dr Santosh Kulkarni takes on the role of Vice President – Medicinal Chemistry. Their wealth of experience promises to […]
Read more

2023.12.21

Sai Life Sciences wins Gold in Brandon Hall Group’s Excellence in Technology Awards

Sai Life Sciences won Gold in Brandon Hall Group’s Excellence in Technology Awards in the ‘Best Advance in Content Authoring Technology’ category. Sai Life Sciences was recognized for the use of UL Create Tool, an easy-to-use, cloud-based authoring tool from UL Solutions, for making the learning process seamless and effective for all. The company utilized […]
Read more

2023.08.21

Sai Life Silver Jubilee year

Sai Life Sciences enters its Silver Jubilee year; surpasses vision of 25 commercial molecules by 2025

Sai Life Sciences entered its Silver Jubilee year with aplomb, surpassing its vision of supporting global innovator partners in bringing 25 new medicines to market by 2025. The company crossed this milestone two years ahead of schedule and is poised to sustain this momentum on the back of a strong portfolio of molecules at various […]
Read more